Solstice Advanced Materials
SOLSNASDAQUSD
- — Source valuation snapshot. Not a live recalculation.
- — Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- — Diluted earnings per share from the latest filed annual.
- $65.02 Prior regular-session close from the quote source.
- $65.68–$67.76 Regular-session low and high so far today.
- 2.0M Regular-session shares traded · Nov 11, 4:00 PM ET.
- Feb 10 projected Projected for 2027-02-10 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
- $40.43–$90.80 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own SOLS if those regulatory tailwinds and its large‑scale investments translate into restored margins and cash after the 2025 balance‑sheet shock.
SOLS price history
Loading recent earnings…
INVESTMENT THESIS
What must happen next
Regulatory transitions to next‑generation, low‑GWP refrigerants will keep core product demand stable-to-growing and allow Solstice to maintain pricing power, because customers must buy compliant chemistries from qualified suppliers.HoldingMateriality: High
Revenue increased from 3,649,000,000 (2023) to 3,886,000,000 (2025), showing continued baseline demand. If true, revenue and pricing power will be durable and investment in capacity will pay off; if false, volumes and prices could fall and leave new capacity underutilized.
Watch: Regulators choose or accelerate policies that favor non‑fluorinated alternatives (making current chemistries less relevant).
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Revenue increased from 3,649,000,000 (2023) to 3,886,000,000 (2025), showing continued baseline demand.
Open source ↗The AES facility expansion and other large scale manufacturing investments (including DOE cost‑sharing) create a capital‑intensive barrier to entry that secures long‑term volumes for Solstice and supports margins if the facility ramps successfully.StrengtheningMateriality: High
Total assets rose from 5,004,000,000 (2024) to 5,673,000,000 (2025), consistent with large capital investments. If capacity comes online and is cost‑competitive, Solstice should capture incremental demand and defend pricing; if it is delayed or overbudget, the company may carry underutilized assets and higher costs.
Watch: Construction delays, major cost overruns, or DOE funding withdrawal that delay commercial production.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Total assets rose from 5,004,000,000 (2024) to 5,673,000,000 (2025), consistent with large capital investments.
Open source ↗Raw material price volatility, scarcity and supplier constraints will show up as pressure on operating cash flow and margins unless Solstice can pass costs to customers or hedge inputs effectively.StrengtheningMateriality: Medium
Operating cash flow declined from 842,000,000 (2024) to 455,000,000 (2025), indicating stress in cash conversion. Operating cash flow and margin resilience determines free cash flow available for deleveraging, dividends or buybacks; persistent cash pressure forces dilution or deferral of strategic investments.
Watch: Inability to pass rising input costs through contracts or the market because customers push back or competitors absorb costs.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Operating cash flow declined from 842,000,000 (2024) to 455,000,000 (2025), indicating stress in cash conversion.
Open source ↗The large increase in liabilities in 2025 materially raises financing risk and could constrain operations or force equity dilution if not resolved or refinanced.StrengtheningMateriality: Medium
Liabilities increased from 1,822,000,000 (2024) to 4,296,000,000 (2025), a large balance‑sheet change. A deteriorated balance sheet limits flexibility to complete AES ramp, invest in R&D, or ride through cyclical stress; resolving it is necessary for the valuation to be sustained.
Watch: A multi‑year legal or environmental liability, regulatory fine, or settlement that requires large cash outflows.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Liabilities increased from 1,822,000,000 (2024) to 4,296,000,000 (2025), a large balance‑sheet change.
Open source ↗The stock price is pricing a recovery of EPS and operating cash flow toward earlier levels; investors require visible evidence of margin and EPS normalization for the multiple to be justified.HoldingMateriality: Medium
Diluted EPS fell from 3.91 (2023) to 3.74 (2024) to 1.49 (2025), showing the earnings hit that must be reversed. If EPS and cash do not recover, the current high multiple will compress; conversely, a demonstrable recovery would validate the valuation and allow upside.
Watch: Sustained lower margins and EPS from recurring higher input costs, structural pricing pressure, or permanent demand decline.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Diluted EPS fell from 3.91 (2023) to 3.74 (2024) to 1.49 (2025), showing the earnings hit that must be reversed.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Regulatory transitions to next‑generation, low‑GWP refrigerants will keep core product demand stable-to-growing and allow Solstice to maintain pricing power, because customers must buy compliant chemistries from qualified suppliers. If true, revenue and pricing power will be durable and investment in capacity will pay off; if false, volumes and prices could fall and leave new capacity underutilized.
The AES facility expansion and other large scale manufacturing investments (including DOE cost‑sharing) create a capital‑intensive barrier to entry that secures long‑term volumes for Solstice and supports margins if the facility ramps successfully. If capacity comes online and is cost‑competitive, Solstice should capture incremental demand and defend pricing; if it is delayed or overbudget, the company may carry underutilized assets and higher costs.
Raw material price volatility, scarcity and supplier constraints will show up as pressure on operating cash flow and margins unless Solstice can pass costs to customers or hedge inputs effectively. Operating cash flow and margin resilience determines free cash flow available for deleveraging, dividends or buybacks; persistent cash pressure forces dilution or deferral of strategic investments.
The large increase in liabilities in 2025 materially raises financing risk and could constrain operations or force equity dilution if not resolved or refinanced. A deteriorated balance sheet limits flexibility to complete AES ramp, invest in R&D, or ride through cyclical stress; resolving it is necessary for the valuation to be sustained.
The stock price is pricing a recovery of EPS and operating cash flow toward earlier levels; investors require visible evidence of margin and EPS normalization for the multiple to be justified. If EPS and cash do not recover, the current high multiple will compress; conversely, a demonstrable recovery would validate the valuation and allow upside.
All standing thesis claims
Original report summary
those regulatory tailwinds and its large‑scale investments translate into restored margins and cash after the 2025 balance‑sheet shock.
Bull case and bear case
Bull case and bear case for Solstice Advanced Materials
Where the evidence on Solstice Advanced Materials stands: Holding on the latest evidence (Nov 10, 2026). Of its 5 thesis points, 3 strengthening and 2 holding.
Bull case: what the evidence supports
Regulatory transitions to next‑generation, low‑GWP refrigerants will keep core product demand stable-to-growing and allow Solstice to maintain pricing power, because customers must buy compliant chemistries from qualified suppliers.
The AES facility expansion and other large scale manufacturing investments (including DOE cost‑sharing) create a capital‑intensive barrier to entry that secures long‑term volumes for Solstice and supports margins if the facility ramps successfully.
Raw material price volatility, scarcity and supplier constraints will show up as pressure on operating cash flow and margins unless Solstice can pass costs to customers or hedge inputs effectively.
The large increase in liabilities in 2025 materially raises financing risk and could constrain operations or force equity dilution if not resolved or refinanced.
The stock price is pricing a recovery of EPS and operating cash flow toward earlier levels; investors require visible evidence of margin and EPS normalization for the multiple to be justified.
Bear case: what would count against it
Regulators choose or accelerate policies that favor non‑fluorinated alternatives (making current chemistries less relevant).
Construction delays, major cost overruns, or DOE funding withdrawal that delay commercial production.
Inability to pass rising input costs through contracts or the market because customers push back or competitors absorb costs.
Thesis-Break Engine
Thesis-break watch · Solstice Advanced Materials
No break has crossed Solstice Advanced Materials’s thesis. Its break conditions are checked against every new filing as it lands.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MIXEDReported results of operations (earnings release).
Solstice Advanced Materials filed an SEC 8-K on 2026-11-04: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
- MIXEDOther material event.
Solstice Advanced Materials filed an SEC 8-K on 2026-11-03: Other material event. It is a dated development that tests the current thesis.
- MIXEDEntered a material definitive agreement.
Solstice Advanced Materials filed an SEC 8-K on 2026-08-27: Entered a material definitive agreement. It is a dated development that tests the current thesis.
RISKS / FALSIFIERS
What could break the thesis
- Regulators choose or accelerate policies that favor non‑fluorinated alternatives (making current chemistries less relevant).
- Construction delays, major cost overruns, or DOE funding withdrawal that delay commercial production.
- Inability to pass rising input costs through contracts or the market because customers push back or competitors absorb costs.
- A multi‑year legal or environmental liability, regulatory fine, or settlement that requires large cash outflows.
- Sustained lower margins and EPS from recurring higher input costs, structural pricing pressure, or permanent demand decline.
SOLS news
Loading headlines…
FINANCIAL STATEMENTS
SOLS income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
SOLS: quick answers
- When does Solstice Advanced Materials (SOLS) report earnings next?
- Solstice Advanced Materials's next results are projected for February 10, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on November 4, 2026. Earnings calendar
- What is SOLS's short interest?
- As of October 30, 2026, 4.7M SOLS shares were sold short, 2.97% of its shares outstanding, down 5.7% from the count before. At the stock's average daily volume that is 2.2 days to cover. FINRA publishes the count twice a month. SOLS short interest history
- Have members of Congress traded SOLS?
- Reports made public in the last 90 days disclose 3 trades in SOLS by 3 filers: 0 purchases and 3 sales. They are filed under the STOCK Act by members of Congress, the President and senior officials. Every disclosed SOLS trade
- Which well-known investors own SOLS?
- 1 of the 37 well-known funds tracked here reported SOLS shares in their latest 13F filing. By share of the fund's portfolio: Duquesne Family Office (Stanley Druckenmiller), 0.1%. Fund portfolios
SOLS in well-known investors’ portfolios
1 of 37 funds reported SOLS shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.
| Fund | Of its portfolio | Value | Change | Quarter |
|---|---|---|---|---|
| Stanley DruckenmillerDuquesne Family Office | 0.11% | $5.5M | No change | Q2 2026 |
